NEW YORK, Dec. 19, 2017 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. (“Novavax” or the “Company”) (NASDAQ: NVAX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
Th…
